Mounjaro, a weight loss drug launched by Eli Lilly in India, could be a game-changer and has been making waves lately. Here's ...
Mounjaro, a weekly injection, targets GIP and GLP-1 hormones to enhance insulin release and appetite regulation, aiding ...
Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight ...
As research continues, Mounjaro may redefine medical weight loss strategies, but its ethical implications and long-term ...
Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...
FROM nausea to constipation, we’ve all heard about the possible brutal side effects of fat jabs – but how familiar are you ...
In an interview with 'Self,' influencer Remi Bader opened up about her difficult experience with the weight loss drug Ozempic ...
Now, Eli Lilly, the largest pharmaceutical company in the world in terms of market capitalisation, has launched its own ...
JM Financial is bullish on Mounjaro's success in India, citing its price advantage, higher efficiency and the country's large ...
Eli Lilly has launched Mounjaro in India, a new once-weekly injectable drug for type 2 diabetes and weight management.
Amy Schumer recently took to her Instagram handle to share her experience with Midi Health. The 43-year-old actress-comedian ...
Amy Schumer admitted she was using a new weight loss medication and praised the many benefits of Mounjaro after difficult time using Ozempic years ago.